Aiforia Technologies

Next in our interview series "AI stories by Aiforia users," Dr. Vincenzo L'Imperio and Prof. Fabio Pagni from an Italian research team describe their journey of building an AI algorithm with Aiforia® Create, Aiforia’s versatile AI development tool, for assisting in the process of kidney transplantation. 📝 Read the blog post to learn more about their experience: https://hubs.la/Q02PhglP0 🎥 Watch the full interview here: https://hubs.la/Q02Phg6K0

Today, we had the pleasure of hosting Maxwell Smith, M.D., Pathologist at the Mayo Clinic, in our Helsinki office. His experiences using Aiforia Create to build AI models for interstitial lung disease and liver transplantation sparked a lot of interest and discussion. Thank you for the visit and a great presentation! #AI #digitalpathology #pathology

The 36th European Congress of Pathology (ECP 2024) organized by the European Society of Pathology in Florence, Italy is ongoing. Stop by booth number 73 to meet Aiforia's team. Today, on September 10th, make sure to join the Aiforia-related presentations and posters listed below: 🕙 15:45-17:45 (CEST; UTC +2) SC-18-002 Computational and integrative pathology from diagnosis to prediction: an Italian experience by Vincenzo L'Imperio, University of Milan-Bicocca 🕙 18:30-20:30 (CEST; UTC +2) SC-21 Debating the pros and cons of AI topics by Inti Zlobec, Universität Bern, Zentraler, Rechnungseingang (chair), Catherine Guettier, Hôpital Bicêtre, APHP, Vincenzo L'Imperio, University of Milan-Bicocca Don't miss the chance to see the Aiforia® Platform in action, and secure a time for a meeting here: https://hubs.la/Q02PhgpD0 #ESPCongress #ECP #ECP2024 #digitalpathology #pathology

ENG: Aiforia's CEO Jukka Tapaninen is attending the Kauppalehti Stock Market Investor Week today. Tune in at 12:40 pm EEST today to hear his presentation on the future of AI-powered diagnostics in pathology. FIN: Aiforian toimitusjohtaja Jukka Tapaninen on mukana Pörssisijoittajan viikko -tapahtumassa tänään klo 12:40. Puheenvuoron aiheena tekoälyn tukeman diagnostiikan rooli patologian digitaalisessa muutoksessa. Register / Ilmoittaudu: https://hubs.la/Q02P4Rwn0

Greetings from the 36th European Congress of Pathology (ECP 2024) organized by the European Society of Pathology in Florence, Italy. Visit our booth number 73, and attend the following Aiforia-related presentations and posters happening at the event today, on September 9th: 🕙 9:30-10:30 (CEST; UTC +2) PS-01-001 Automated detection and classification of hematopoietic cells in bone marrow aspirate smears for routine screening using a deep-learning algorithm (Aiforia) by Leonie Saft, Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital 🕙 15:45-17:45 (CEST; UTC +2) OFP-06-004 Reticulin framework alterations in paragangliomas: do they matter at all? by Eleonora Duregon, University of Turin, Italy (Prof. Papotti's research group) Would like to learn more about how AI-assisted image analysis can increase efficiency, precision, and consistency in the pathology workflow? Book a demo to see AI in action on-site: https://hubs.la/Q02P3Br30 #ECP2024 #ECP #ESPCongress #AI #digitalpathology #pathology

Today is the day! Aiforia is at the 36th European Congress of Pathology (ECP 2024) organized by the European Society of Pathology in Florence, Italy. Join the following Aiforia-related presentations and posters today, on September 8th: 🕙 10:30-11:30 (CEST; UTC +2) PS-02-018 A threefold evaluation of HER2low status of advanced breast carcinomas in core biopsies, matching surgical specimens and their distant metastases. A retrospective study of 47 patients using conventional microscopy, digital pathology and AI by Anikó Kovács, Department of Clinical Pathology, Sahlgrenska University Hospital 🕙 15:45-17:45 (CEST; UTC +2) CP-02-006 Deep learning predicts the effect of neo-adjuvant chemotherapy for patients with triple negative breast cancer by Bart Sturm, Pathan B.V., Netherlands (Under Research Lead: Prof. Jeroen van der Laak) 🗓️ See the full agenda for these upcoming conference days, and get in touch with Aiforia's team: https://hubs.ly/Q02P2qw_0 #ECP #ECP2024 #ESPCongress #pathology #digitalpathology

On September 21-24, we will be at the National Society for Histotechnology (NHS) Convention in New Orleans, LA! Meet John Wagner and Colin Ziabakhsh at booth number 613 to learn more about Aiforia’s powerful deep learning AI and cloud-based technology. 🖥️ Book a slot for a personalized demo to see in action how Aiforia's solutions strive to increase the speed, accuracy, and consistency of analyzing large and complex medical images, especially in pathology: https://hubs.la/Q02NXG1X0 #digitalpathology #AI

Assistance Publique–Hôpitaux de Paris (AP-HP) has selected Aiforia Technologies Plc as a partner for AI-assisted pathology image analysis in clinical diagnostics. The collaboration involves the use of the Aiforia Clinical AI solutions for the analysis of tissue samples from prostate cancer patients. Read more: https://hubs.la/Q02NM2Tn0

As a part of our interview series "AI stories by Aiforia users", Professors Mauro Papotti and Eleonora Duregon from the University of Turin share their experience utilizing Aiforia® Create to build an AI model for mesothelioma subtyping with reticulin stain. Watch their interview to learn more about AI-powered mesothelioma research: https://hubs.la/Q02Nm2wg0 Read the blog post to find out more: https://lnkd.in/d2dCxNN9

ENG: Aiforia reinforces its Management Team to strengthen the implementation of the company’s growth strategy. Join us in congratulating Tamas Regenyi for his new appointment as Chief Commercial Officer and as a member of Aiforia's Management Team! FIN: Aiforia täydentää johtoryhmäänsä vahvistaakseen yhtiön kasvustrategian toteuttamista. Tamas Regenyi on nimitetty Aiforian kaupalliseksi johtajaksi ja johtoryhmän jäseneksi. Onnea! Read more/ Lue lisää: https://hubs.la/Q02Nlsvx0